Literature DB >> 15721762

Assessment of Tc-99m sestamibi tumor tissue uptake under the influence of increased arterial oxygen saturation.

Tevfik Fikret Cermik1, Gundeniz Altiay, Mehmet Fatih Firat, Osman N Hatipoglu, Sakir Berkarda.   

Abstract

The aim of this study is to investigate the potential effect of increased arterial saturation of oxygen in the magnitude of technetium-99m-hexakis-isobutyl-isonitrile (99mTc-MIBI) uptake in tumor tissue and to compare the results with those of conventional 99mTc-MIBI tumor imaging in the same patient with lung cancer. A total of 26 lung cancer patients underwent initial SPECT (I-SPECT) and after oxygen inhalation SPECT (O2-SPECT). The early (ER) and delayed ratios (DR) of O2-SPECT mean+/-S.D. were significantly higher than those of I-SPECT mean+/-S.D. (2.07+/-0.57 vs. 1.90+/-0.48 and 2.02+/-0.45 vs. 1.83+/-0.39, respectively). There are increased rates for the relative tumor uptake of 99mTc-MIBI by 9% for ER and 10% for DR on the O2-SPECT compared to I-SPECT. We found that 99mTc-MIBI uptake increased significantly in the tumor tissue with O2-SPECT compared to I-SPECT. In conclusion, 99mTc-MIBI scintigraphy is one of the main methods for differentiating viable and nonviable tissue fractions in tumors. We consider that 99mTc-MIBI uptake increase after oxygen inhalation is an indicator of positive acute cellular response of the tumor tissue to the rising tissue oxygen level.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15721762     DOI: 10.1016/j.nucmedbio.2004.12.003

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  2 in total

Review 1.  Radionuclide imaging of perfusion and hypoxia.

Authors:  George Laking; Pat Price
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

2.  Lung 99mTc-MIBI scintigraphy: impact on diagnosis of solitary pulmonary nodule.

Authors:  Katarina Nikoletic; Silvija Lucic; Andrea Peter; Violeta Kolarov; Radmila Zeravica; Dolores Srbovan
Journal:  Bosn J Basic Med Sci       Date:  2011-08       Impact factor: 3.363

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.